WY
60
7
CRM
59
2
RCL
74
4
FLR
48
6
PRGO
50
3
CHK
27
5
BA
36
-4
WHR
50
7
AVGO
52
-19
SPG
53
2
NWSA
54
2
F
43
3
SE
65
4
AAL
50
-3
VRSK
56
16
MLM
50
3
IP
42
3
PDCO
57
5
GE
82
5
ZBH
59
3
WY
60
7
CRM
59
2
RCL
74
4
FLR
48
6
PRGO
50
3
CHK
27
5
BA
36
-4
WHR
50
7
AVGO
52
-19
SPG
53
2
NWSA
54
2
F
43
3
SE
65
4
AAL
50
-3
VRSK
56
16
MLM
50
3
IP
42
3
PDCO
57
5
GE
82
5
ZBH
59
3
Financhill
Back

Molecular Partners AG Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
38

MOLN
Molecular Partners AG

Last Price:
5.22
Seasonality Move:
-13.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Hope Is Not a Strategy!

Learn More

Molecular Partners AG Price Quote

$5.22

Molecular Partners AG Key Stats

Sell
38
Molecular Partners AG (MOLN) is a Sell
Day range:
$5.11 - $5.33
52-week range:
$3.32 - $12.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.34
P/B ratio:
1%
Volume:
5.4K
Avg. volume:
7.8K
1-year change:
6.53%
Market cap:
$173.2M
Revenue:
$7.8M
EPS:
$-1.97

How Much Does Molecular Partners AG Make?

Is Molecular Partners AG Growing As A Company?

  • What Is Molecular Partners AG's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.71%
  • What Is Molecular Partners AG's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Molecular Partners AG Stock Price Performance

What Is Molecular Partners AG 52-Week High & Low?

Molecular Partners AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Molecular Partners AG?

Is Molecular Partners AG Cash Flow Positive?

  • What Is MOLN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.8M
  • What Is Molecular Partners AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3M
  • What Is Molecular Partners AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $75.5M

Molecular Partners AG Return On Invested Capital

  • Is Management Doing A Good Job?
    MOLN return on invested capital is -32.02%
  • What Is Molecular Partners AG Return On Assets?
    ROA measures how assets are converting to revenues and is -28.81%
  • What Is MOLN Return On Equity?
    ROE is a measure of profitability and is -32.02%

Molecular Partners AG Earnings Date & Stock Price

Molecular Partners AG Competitors

Molecular Partners AG Dividend Yield

Molecular Partners AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 271.43% 112.78%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 9.51
Upside from Last Price: 82.27%

Major Shareholders

  • How many MOLN shares are owned by institutional investors?
    9.6M MOLN shares are owned by institutional investors
  • How many MOLN shares are owned by insiders?
    0 MOLN shares are owned by insiders